✦ LIBER ✦

The effect of treatment with the oral growth hormone (GH) secretagogue MK-677 on GH isoforms

✍ Scribed by J. Svensson; C.L. Boguszewski; F. Shibata; B. Carlsson; L.M.S. Carlsson; B.-Å. Bengtsson

Book ID: 117734273
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 118 KB
Volume: 13
Category: Article
ISSN: 1096-6374
DOI: 10.1016/s1096-6374(02)00138-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of obese subjects with the ora

Treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 does not increase lipoprotein(A) concentrations

✍ J Svensson; M Ottosson; J-O Jansson; O Wiklund; B-Å Bengtsson 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Two-Month Treatment of Obese Subjects wi

Two-Month Treatment of Obese Subjects with the Oral Growth Hormone (GH) Secretagogue MK-677 Increases GH Secretion, Fat-Free Mass, and Energy Expenditure

✍ Svensson, J. 📂 Article 📅 1998 🏛 Endocrine Society 🌐 English ⚖ 168 KB

Two-Month Treatment of Obese Subjects wi

Two-Month Treatment of Obese Subjects with the Oral Growth Hormone (GH) Secretagogue MK-677 Increases GH Secretion, Fat-Free Mass, and Energy Expenditure 1

✍ Svensson, J.; Lönn, L.; Jansson, J.-O.; Murphy, G.; Wyss, D.; Krupa, D.; Cerchio 📂 Article 📅 1998 🏛 Endocrine Society 🌐 English ⚖ 174 KB

Oral Administration of Growth Hormone (G

Oral Administration of Growth Hormone (GH) Releasing Peptide-Mimetic MK-677 Stimulates the GH/Insulin-Like Growth Factor-I Axis in Selected GH-Deficient Adults

✍ Chapman, I. M. 📂 Article 📅 1997 🏛 Endocrine Society 🌐 English ⚖ 440 KB

Effects of chronic treatment with an ora

Effects of chronic treatment with an oral growth hormone (GH) secretagogue on nocturnal GH and IGF-I in older men and women

✍ G.R. Merriam; M.R. Blackman; A.R. Hoffman; R. Salvatori; J.Y. Wei; H.K. White; M 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Synthesis of the orally active spiroindo

Synthesis of the orally active spiroindoline-based growth hormone secretagogue, MK-677

✍ Peter E. Maligres; Ioannis Houpis; Kai Rossen; Audrey Molina; Jess Sager; Veena 📂 Article 📅 1997 🏛 Elsevier Science 🌐 French ⚖ 706 KB

The preparation of the Merck Growth Hormone Secretagogue; MK-677 is described. A Fischer indole/reduction based strategy provides the novel spiroindoline nucleus of this potent compound. This optimized sequence necessitates the isolation of only one intermediate 10 and provides MK-677 in 48% overall